Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study

Background: Epstein-Barr virus (EBV)-related malignancies harbour distinct serological responses to EBV antigens. We hypothesized that EBV serological patterns can be useful to identify different stages of chronic lymphocytic leukemia. Methods: Information on 150 cases with chronic lymphocytic leuke...

Descripción completa

Detalles Bibliográficos
Autores: Casabonne, Delphine, Benavente, Yolanda, Robles Hellín, Claudia, 1980-, Costas, Laura, Alonso, Esther, González, Eva, Tardón, Adonina, Dierssen Sotos, Trinidad, Gimeno Vázquez, Eva, Aymerich, Marta, Campo, Elias, Castaño Vinyals, Gemma, Aragonés, Núria, Pollán, Marina, Kogevinas, Manolis, Juwana, Hedy, Middeldorp, Jaap, de Sanjosé, Silvia
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/23825
Acceso en línea:http://hdl.handle.net/10230/23825
http://dx.doi.org/10.1186/1750-9378-10-5
Access Level:acceso abierto
Palabra clave:Leucèmia limfocítica crònica
Virus d&apos
Epstein-Barr
Chronic lymphocytic leukemia
Epstein-Barr virus
Serology
Case-control
Smoking
id ES_da34bc56e550f6b0e6b153fe063f44b5
oai_identifier_str oai:repositori.upf.edu:10230/23825
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
title Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
spellingShingle Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
Casabonne, Delphine
Leucèmia limfocítica crònica
Virus d&apos
Epstein-Barr
Chronic lymphocytic leukemia
Epstein-Barr virus
Serology
Case-control
Smoking
title_short Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
title_full Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
title_fullStr Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
title_full_unstemmed Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
title_sort Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
dc.creator.none.fl_str_mv Casabonne, Delphine
Benavente, Yolanda
Robles Hellín, Claudia, 1980-
Costas, Laura
Alonso, Esther
González, Eva
Tardón, Adonina
Dierssen Sotos, Trinidad
Gimeno Vázquez, Eva
Aymerich, Marta
Campo, Elias
Castaño Vinyals, Gemma
Aragonés, Núria
Pollán, Marina
Kogevinas, Manolis
Juwana, Hedy
Middeldorp, Jaap
de Sanjosé, Silvia
author Casabonne, Delphine
author_facet Casabonne, Delphine
Benavente, Yolanda
Robles Hellín, Claudia, 1980-
Costas, Laura
Alonso, Esther
González, Eva
Tardón, Adonina
Dierssen Sotos, Trinidad
Gimeno Vázquez, Eva
Aymerich, Marta
Campo, Elias
Castaño Vinyals, Gemma
Aragonés, Núria
Pollán, Marina
Kogevinas, Manolis
Juwana, Hedy
Middeldorp, Jaap
de Sanjosé, Silvia
author_role author
author2 Benavente, Yolanda
Robles Hellín, Claudia, 1980-
Costas, Laura
Alonso, Esther
González, Eva
Tardón, Adonina
Dierssen Sotos, Trinidad
Gimeno Vázquez, Eva
Aymerich, Marta
Campo, Elias
Castaño Vinyals, Gemma
Aragonés, Núria
Pollán, Marina
Kogevinas, Manolis
Juwana, Hedy
Middeldorp, Jaap
de Sanjosé, Silvia
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Leucèmia limfocítica crònica
Virus d&apos
Epstein-Barr
Chronic lymphocytic leukemia
Epstein-Barr virus
Serology
Case-control
Smoking
topic Leucèmia limfocítica crònica
Virus d&apos
Epstein-Barr
Chronic lymphocytic leukemia
Epstein-Barr virus
Serology
Case-control
Smoking
description Background: Epstein-Barr virus (EBV)-related malignancies harbour distinct serological responses to EBV antigens. We hypothesized that EBV serological patterns can be useful to identify different stages of chronic lymphocytic leukemia. Methods: Information on 150 cases with chronic lymphocytic leukemia and 157 frequency-matched (by age, sex and region) population-based controls from a Spanish multicentre case-control study was obtained. EBV immunoglobulin G serostatus was evaluated through a peptide-based ELISA and further by immunoblot analysis to EBV early antigens (EA), nuclear antigen (EBNA1), VCA-p18, VCA-p40 and Zebra. Two independent individuals categorized the serological patterns of the western blot analysis. Patients with very high response and diversity in EBV-specific polypeptides, in particular with clear responses to EA-associated proteins, were categorized as having an abnormal reactive pattern (ab_EBV). Adjusted odds ratios (OR) and 95% confidence interval (CI) were estimated using logistic regression models. Results: Almost all subjects were EBV-IgG positive (>95% of cases and controls) whereas ab_EBV patterns were detected in 23% of cases (N = 34) and 11% of controls (N = 17; OR: 2.44, 95% CI, 1.29 to 4.62; P = 0.006), particularly in intermediate/high risk patients. Although based on small numbers, the association was modified by smoking with a gradual reduction of ab_EBV-related OR for all Rai stages from never smokers to current smokers. Conclusions: Highly distinct EBV antibody diversity patterns revealed by immunoblot analysis were detected in cases compared to controls, detectable at very early stages of the disease and particularly among non smokers. This study provides further evidence of an abnormal immunological response against EBV in patients with chronic lymphocytic leukemia.
publishDate 2015
dc.date.none.fl_str_mv 2015
2015
2015
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/23825
http://dx.doi.org/10.1186/1750-9378-10-5
url http://hdl.handle.net/10230/23825
http://dx.doi.org/10.1186/1750-9378-10-5
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Infectious Agents and Cancer. 2015;10:5
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421531506933760
spelling Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control studyCasabonne, DelphineBenavente, YolandaRobles Hellín, Claudia, 1980-Costas, LauraAlonso, EstherGonzález, EvaTardón, AdoninaDierssen Sotos, TrinidadGimeno Vázquez, EvaAymerich, MartaCampo, EliasCastaño Vinyals, GemmaAragonés, NúriaPollán, MarinaKogevinas, ManolisJuwana, HedyMiddeldorp, Jaapde Sanjosé, SilviaLeucèmia limfocítica crònicaVirus d&aposEpstein-BarrChronic lymphocytic leukemiaEpstein-Barr virusSerologyCase-controlSmokingBackground: Epstein-Barr virus (EBV)-related malignancies harbour distinct serological responses to EBV antigens. We hypothesized that EBV serological patterns can be useful to identify different stages of chronic lymphocytic leukemia. Methods: Information on 150 cases with chronic lymphocytic leukemia and 157 frequency-matched (by age, sex and region) population-based controls from a Spanish multicentre case-control study was obtained. EBV immunoglobulin G serostatus was evaluated through a peptide-based ELISA and further by immunoblot analysis to EBV early antigens (EA), nuclear antigen (EBNA1), VCA-p18, VCA-p40 and Zebra. Two independent individuals categorized the serological patterns of the western blot analysis. Patients with very high response and diversity in EBV-specific polypeptides, in particular with clear responses to EA-associated proteins, were categorized as having an abnormal reactive pattern (ab_EBV). Adjusted odds ratios (OR) and 95% confidence interval (CI) were estimated using logistic regression models. Results: Almost all subjects were EBV-IgG positive (>95% of cases and controls) whereas ab_EBV patterns were detected in 23% of cases (N = 34) and 11% of controls (N = 17; OR: 2.44, 95% CI, 1.29 to 4.62; P = 0.006), particularly in intermediate/high risk patients. Although based on small numbers, the association was modified by smoking with a gradual reduction of ab_EBV-related OR for all Rai stages from never smokers to current smokers. Conclusions: Highly distinct EBV antibody diversity patterns revealed by immunoblot analysis were detected in cases compared to controls, detectable at very early stages of the disease and particularly among non smokers. This study provides further evidence of an abnormal immunological response against EBV in patients with chronic lymphocytic leukemia.This work was supported by the “Acción Transversal del Cancer”, approved on the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III (Spanish Government) (grants PI08/1770, PI08/0533, PI08/1359, PS09/00773-Cantabria, PI11/01810, PI11/02213, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RTIC RD12/0036/0056, Rio Hortega CM13/00232, SV-09-CLINIC-1 and CIBERESP), by the Fundación Marques de Valdecilla (API 10/09), by Obra Social CAJASTUR (SV-CAJASTUR-1), by the Recercaixa (2010ACUP 00310), by the Spanish Association Against Cancer (AECC) Scientific Foundation and by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR)–Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2009SGR1026, 2014SGR756 and 2009SGR1465). The ICGC CLL-Genome Project is funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTIC RD12/0036/0036) del ISCIII. Sample collection and storage was partially supported by the Instituto de Salud Carlos III FEDER (RD09/0076/00036), Xarxa de Bancs de Tumors de Catalunya sponsored by Pla Director d’Oncologia de Catalunya (XBTC).BioMed Central201520152015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/23825http://dx.doi.org/10.1186/1750-9378-10-5reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésInfectious Agents and Cancer. 2015;10:5© 2015 Casabonne et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/238252026-06-12T07:21:37Z
score 15.198674